androstenediol has been researched along with Shock, Septic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auci, D; Frincke, J; Mangano, K; Morgan, L; Nicoletti, F; Nierkens, S; Offner, H; Pieters, R; Reading, C | 1 |
Ben-Nathan, D; Loria, RM; Padgett, DA | 1 |
2 other study(ies) available for androstenediol and Shock, Septic
Article | Year |
---|---|
Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases.
Topics: Amino Acid Sequence; Androstenediol; Androstenols; Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Pleurisy; Shock, Septic | 2005 |
Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity.
Topics: Androstenediol; Animals; Dehydroepiandrosterone; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Interleukin-1; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Pseudomonas Infections; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |